What drove the cycles of Chinese health system reforms?

Health Systems and Reform

Volumn 1, Issue 1, 2015, Pages 52-61

  Yip, Winnie ^a   Hsiao, William C ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

China; Health care delivery; Health care financing; Health care reform; Privatization; Role of government; Role of market

Indexed keywords

EID: 84926323850     PISSN: 23288604     EISSN: 23288620     Source Type: Journal    
DOI: 10.4161/23288604.2014.995005     Document Type: Article

References (59)

1. Blumenthal D, Hsiao W. Privatization and its discontents—the evolving Chinese health care system. N Engl J Med 2005; 353: 1165–70.
2. Hu S, Tang S, Liu Y, Zhao Y, Escobar M-L, de Ferranti D. Reform of how health care is paid for in China: challenges and opportunities. Lancet 2008; 372: 1846–53.
3. Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M. Tackling the challenges to health equity in China. Lancet 2008; 372: 1493–501.
4. Yip W, Hsiao WC. The Chinese health system at a crossroads. Health Affairs 2008; 27: 460–8.
5. Yip WC-M, Hsiao W, Meng Q, Chen W, Sun X. Realignment of incentives for health-care providers in China. Lancet 2010; 375: 1120–30.
6. Hsiao WC. Correcting past health policy mistakes. Daedalus 2014; 143: 53–68.
7. Meng Q, Xu L, Zhang Y, Qian J, Cai M, Xin Y, Gao J, Xu K, Boerma J, Barber SL. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet 2012; 379: 805–14.
8. Yip WC-M, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of China’s huge and complex health-care reforms. Lancet 2012; 379: 833–42.
9. Lin JY, Cai F, Li Z. The China miracle: development strategy and economic reform. Beijing: Chinese University Press; 2003.
10. North DC, Weingast BR. Constitutions and commitment: the evolution of institutions governing public choice in seven-teenth-century England. J Econ Hist 1989; 49: 803–32.
11. Ostrom V, Ostrom E. Public goods and public choices. In: McGinnis M, ed. Polycentricity and local public economies readings from the workshop in political theory and policy analysis. Ann Arbor: University of Michigan Press; 1999: 75–105.
12. Friedman M. Capitalism and freedom. Chicago: University of Chicago Press; 2002.
13. Hayek FA. The constitution of liberty: the definitive edition. Routledge; 2013.
14. Arrow KJ. The organization of economic activity: issues pertinent to the choice of market vs. nonmarket allocation. In: The analysis and evaluation of public expenditure: the PPB system. Joint Economic Committee, 91st Cong., 1st sess., vol. 1. Washington, DC: Government Printing Office; 1969; 59–73.
15. Roberts M, Hsiao W, Berman P, Reich M. Getting health reform right: a guide to improving performance and equity. Oxford: Oxford University Press; 2008.
16. Stigler GJ. The theory of economic regulation. The Bell Journal of Economics and Management Science 1971; 2: 3–21.
17. Laffont J-J, Tirole J. The politics of government decision-making: A theory of regulatory capture. The Quarterly Journal of Economics 1991; 106: 1089–127.
18. Banerjee AV. A theory of misgovernance. The Quarterly Journal of Economics 1997; 112: 1289–332.
19. Besley T, Coate S. Centralized versus decentralized provision of local public goods: a political economy approach. J Public Econ 2003; 87: 2611–37.
20. Rauch JE, Evans PB. Bureaucratic structure and bureaucratic performance in less developed countries. J Public Econ 2000; 75: 49–71.
21. Stiglitz JE. Markets, market failures, and development. The American Economic Review 1989; 79: 197–203.
22. McGuire TG. Physician agency. Handbook of Health Economics 2000; 1: 461–536.
23. Zhang H. The argument about the new health reform lines: government and market. The Reform and Open-up 2013; 4: 009.
24. Zhu N, Ling Z, Shen J, Lane J, Hu S. Factors associated with the decline of the cooperative medical system and barefoot doctors in rural China. B World Health Organ 1989; 67: 431
25. Hesketh T, Wei XZ. Health in China. From Mao to market reform. BMJ 1997; 314: 1543
26. UNDESA. World population prospects: the 2012 revision. 2012. Available at http://esa.un.org/wpp/(accessed 14 July 2014)
27. Gu X-Y, Tang S-L. Reform of the Chinese health care financing system. Health Policy 1995; 32: 181–91.
28. Qian Y. The process of China’s market transition (1978-1998): the evolutionary, historical, and comparative perspectives. J Inst Theor Econ 2000; 156: 151–71.
29. Naughton B. China’s economy: complacency, crisis & the challenge of reform. Daedalus 2014; 143: 14–25.
30. Yip WC, Hsiao WC. Medical savings accounts: lessons from China. Health Affairs 1997; 16: 244–51.
31. Eggleston K, Ling L, Qingyue M, Lindelow M, Wagstaff A. Health service delivery in China: a literature review. Health Econ 2008; 17: 149–65.
32. State Council of PRC. Opinions on further reforming of health care systems. 1992. Available at http://www.reform data.org/content/19920923/25367.html (accessed 14 July 2014)
33. Li Y, Xu J, Wang F, Wang B, Liu L, Hou W, Fan H, Tong Y, Zhang J, Lu Z. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Affairs 2012; 31: 1075–82.
34. He GX, van den Hof S, van der Werf MJ, Guo H, Hu YL, Fan JH, Zhang WM, Tostado CP, Borgdorff MW. Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals. Clin Inf D 2011; 52: e153-e6
35. Liu X, Mills A. Evaluating payment mechanisms: how can we measure unnecessary care? Health Policy Plann 1999; 14: 409–13.
36. Ou Y, Jing B-Q, Guo F-F, Zhao L, Xie Q, Fang Y-L, Cui J, Xiao W, Wu D-W, Zhou W. Audits of the quality of perioperative antibiotic prophylaxis in Shandong Province, China, 2006 to 2011. Am J Infect Control 2014; 42: 516–20.
37. Reynolds L, McKee M. Serve the people or close the sale? Profit-driven overuse of injections and infusions in China’s market-based healthcare system. The International Journal of Health Planning and Management 2011; 26: 449–70.
38. Ministry of Health of PRC. China health statistical yearbook. Beijing: Peking Union Medical College Press; 2012.
39. National Bureau of Statistics of PRC. China statistical yearbook. Bejing: China Statistics Press; 2012.
40. OECD. OECD health data: health expenditure and financing: health expenditure indicators. 2013. Available at http://www. oecd-ilibrary.org/social-issues-migration-health/data/oecd-health-statistics_health-data-en
41. Ministry of Health of PRC. The main findings of the third National Health Service Survey. 2004. Available at http://www.moh.gov.cn/uploadfile/200412/200412314857549.doc (accessed 15 September 2014)
42. Zhang T, Tang S, Jun G, Whitehead M. Persistent problems of access to appropriate, affordable TB services in rural China: experiences of different socio-economic groups. BMC Public Health 2007; 7: 19
43. Kornreich Y, Vertinsky I, Potter PB. Consultation and deliberation in China: the making of China’s health-care reform. China J 2012: 176–203.
44. Korolev A. Deliberative democracy nationwide?—evaluating deliberativeness of healthcare reform in China. J Chinese Polit Sci 2014; 19: 151–72.
45. Wang S. China’s health system: from crisis to opportunity. Yale-China Health Journal 2004; 3: 5–49.
46. Bloom G. Building institutions for an effective health system: lessons from China’s experience with rural health reform. Soc Sci Med 2011; 72: 1302–9.
47. Hsiao W, Li M, Zhang S. Universal health coverage: the case of China. Boston: Harvard School of Public Health; 2013.
48. Li L, Chen Q, Powers D. China’s healthcare reform and social development. The Center of Chinese Economic Research; 2012. Available at http://www.cenet.org.cn/editor/userfiles/Other/2012-09/2012090610233237412241.pdf(accessed 7/14/2014); 2006.
49. Ge Y, Gong S. Chinese health care reform: problems, reasons and solutions. Beijing: China Development Publishing House; 2007.
50. Thompson D. China’s health care reform redux. 2009. Available at http://www.cftni.org/Thompson-China-Health-Care-Reform-Redux2009.pdf (accessed 14 July 2014)
51. Wu L, Sun Z, Shi Z. Public finance invests more than three trillion RMB in the health reform. Economic Information Daily. Beijing: Xinhua News Agency; 2011.
52. Yang L, Liu C, Ferrier JA, Zhou W, Zhang X. The impact of the National Essential Medicines Policy on prescribing behav-iours in primary care facilities in Hubei province of China. Health Policy Plann 2013; 28(7): 750–60.
53. State Council of PRC. The Twelfth Five-Year Plan for Health Sector Development. Beijing: Author; 2014.
54. National Development and Reform Commission of PRC. Further encouraging and guiding the establishment of medical institutions by social capital. Beijing: Author; 2013.
55. National Health and Family Planning Commission of PRC. Accelerate the development of establishing hospitals with social capital. Beijing: Author; 2014.
56. National Health and Family Planning Commission. Urgent notice of controlling the quick expansion of public hospitals’ sizes. 2014. Available at http://www.gsws.gov.cn/html/2/9/44618.htm (accessed 14 July 2014)
57. 57[57] National Development and Reform Commission of RPC. Opinions about establishing insurance schemes of serious illnesses for urban and rural residents. 2012. Available at http://news.xinhuanet.com/politics/2012-08/30/c_112908096. htm (accessed 14 July 2014)
58. Xinhua News Agency. Li Keqiang chaired a State Council executive meeting and determined to accelerate the development of private health insurance. 2014. Available at http://news.xinhuanet.com/politics/2014-08/27/c_1112255755.htm (accessed 15 September 2014)
59. State Council of PRC. Opinions on promoting the development of health service industries. 2013. Available at http://www.gov.cn/zwgk/2013-10/14/content_2506399.htm (accessed 14 July 2014)